Page results
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
This page explains what sperm banking is, how it works and how it can benefit you.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2023/0034 - Trusts video consultation solutions
-
FOI/2023/0025 - Surgical operating tables used in Trust
-
FOI/2023/0037 - Assault attendances to Emergency Department
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0065 - A&E deaths from 2010 to 2022
-
FOI/2023/0064 - Children's operations cancelled/ delayed for non-clinical reasons from 2018 to 2022
-
FOI/2022/0794 - Communication personnel and communication spend
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0054 - Local formulary used at the Trust